Company Overview and News


Add ASTRAZEN
to your dashboard

Headline News

Torrent Power, Bharat Seats, AstraZeneca Pharma hits 52-wk high on strong Q2 nos

2017-11-07 moneycontrol
Shares Torrent Power, Bharat Seats and AstraZeneca Pharma touched 52-week high, gaining 5-20 percent intraday Tuesday on the back of strong Q2 (July-September) numbers.

AstraZeneca Pharma India Q2 net zooms to Rs 27.38 crore

2017-11-06 moneycontrol
AstraZeneca Pharma India today reported a multi-fold jump in its net profit to Rs 27.38 crore for the quarter ended September 30, 2017 mainly on account of higher revenues and decrease in expenses.

AstraZeneca gets regulator’s nod to sell diabetes drug

2017-10-17 thehindubusinessline
Drug firm AstraZeneca Pharma has received marketing authorisation from the Drug Controller General of India (DCGI) for Xigduo XR tablets used in treatment of adults with type 2 diabetes in India.

AstraZeneca Pharma India gets DCGI nod to market diabetes drug

2017-10-17 business-standard
Drug firm AstraZeneca Pharma has received marketing authorisation from the Drug Controller General of India (DCGI) for Xigduo XR tablets used in treatment of adults with type 2 diabetes in India. The product is indicated as an adjunct therapy to diet and exercise to improve glycemic control in adults with type 2 diabetes, AstraZeneca Pharma India said in a statement.

AstraZeneca Pharma India Limited - Updates

2017-10-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Volumes jump at Thyrocare Technologies counter

2017-10-04 indiainfoline
Atul Auto, Rallis India, Ador Welding and Astrazeneca Pharma India are among the other stocks to see a surge in volumes on BSE today, 4 October 2017. (3-0)

AstraZeneca Pharma India Limited - Shareholders meeting

2017-09-14 feedproxy.google
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Pharma Newsletter- July 24 to July 28, 2017

2017-07-29 indiainfoline
This week, “AstraZeneca Pharma India has received a one month extension from its parent firm AstraZeneca UK to sell anti-bacterial drug Meronem in India. The parent company has given extension due to delay in the divestment of AstraZeneca’s global rights to Meronem.”

AstraZeneca gets extension for withdrawal of Meronem till Aug 31

2017-07-28 thehindubusinessline
AstraZeneca Pharma India has got another month’s extension from its parent firm AstraZeneca UK to sell anti-bacterial drug Meronem in India due to delay in the divestment of AstraZeneca’s global rights to Meronem.

AstraZeneca gets extension for Meronem withdrawal till Aug 31

2017-07-28 moneycontrol
AstraZeneca Pharma India has got another month's extension from its parent firm AstraZeneca UK to sell anti-bacterial drug Meronem in India due to delay in the divestment of AstraZeneca's global rights to Meronem.

AstraZeneca Pharma India Limited - Updates

2017-07-28 feedproxy.google

AstraZeneca Pharma India Limited - Results

2017-07-25 feedproxy.google